Condition: Intracranial Hypertension · Sponsor: Azienda Ospedaliera di Padova
An increase of intracranial pressure (ICP) is an important cause of secondary brain damage. The gold standard for measuring ICP is represented by invasive positioning of intracranial ICP devices. The most used non-invasive methods (nICP) are obtained through bed-side ultrasound, routinely used in the management of children in Pediatric Intensive Care: arterial Trancranial Doppler (TCD) and ultrasound measurement of the diameter of the optic nerve sheath (ONSD ). In this study it is proposed to compare the measurement of nICP obtained by TCD and ONSD versus the measurement obtained by the invasive monitoring (iICP) already present.
This description comes directly from the study's public registry record.
angela amigoni, MD · +39 339 8333765 · angela.amigoni@aopd.veneto.it
Always discuss trial participation with your own doctor first.
| PICU IRCSS Sant'Orsola Malpighi | Bologna, Italy | Not Yet Recruiting |
| PICU Spedali Civili BRescia | Brescia, Italy | Not Yet Recruiting |
| PICU Ospedale Mayer | Florence, Italy | Not Yet Recruiting |
| PICU Ospedale Gaslini | Genova, Italy | Not Yet Recruiting |
| PICU University Hospital Padova | Padova, Italy | Recruiting |
| PICU Università Cattolica | Roma, Italy | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05340062